SOURCE LOGIN
|
中文版
中文
China Pharmaceutical and Biotechnology Monthly
CPB Monthly is the intelligent guide to China's healthcare industry.
Price: 2,400 USD annual subscription
Receive a free copy!
Please enter your email address below to receive a sample issue of the CPB Monthly.
See this month's
Table of Contents
Already a subscriber? Click here to Login.
CPB MONTHLY DESCRIPTION
Filled with news, analysis, and coverage of the financial markets, CPB Monthly is
essential
for anyone serious about
tracking China healthcare
.
Your subscription includes:
CPB Monthly delivered
monthly
in PDF format
CPB Headlines delivered
weekly
in HTML format
Daily
access to full text CPB news briefs online and ability to keyword search for past briefs
(Note: Online access to past CPB issues limited to SOURCE subscribers)
Past issues of the CPB Monthly
CPB Monthly Vol 55 January 2012
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- Love Me Tender: Shanghai Shuffles Procurement Deck
- Private Health Insurance: The Healthcare Financing Option of the Future
- Revisiting Breast Cancer Therapies for Greater Efficacy
GBI CPB Monthly Vol 54 November and December 2011
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- Unscripted Outcomes: Shanghai Pilots Prescription-Free Rx Sales
- Raising the Bar: New GMP Clears Competitive Landscape
- c-MET Inhibitor Programs in China Seeking Answers for Cancer
GBI Monthly Vol 53 October 2011
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- Ending drug markups: Saved by Zero? Or no Fix at all?
- Schizophrenia Treatment in China: A brief look
- Binhui Ni on R&D Partnering Business in China
CPB Monthly Vol 52 September 2011
Price: 250 USD
Page count: 60
Full Table of Contents (PDF)
Lead articles:
- Life in the Fast Lane? New Drug Approvals and Innovation in China
- Lonza-Fosun: A Formidable Generics Tie-up?
- Boon Heon Tan on the Current Landscape of Executive Search in China
CPB Monthly Vol 51 August 2011
Price: 250 USD
Page count: 60
Full Table of Contents (PDF)
Lead articles:
- A New Leaf: Beijing moves Traditional Chinese Medicine to the front burner
- Rough Tendering: Growing dissatisfaction with the "Anhui Model"
- Ralf Altmeyer on Accelerating Global Biotech Companies via Advance BioChina
CPB Monthly Vol 50 july 2011
Price: 250 USD
Page count: 60
Full Table of Contents (PDF)
Lead articles:
- Can the Dragon and the Elephant Tango?
- Antibiotic abuse in China
- Ming-Wei Wang on China's Drug Discovery and Development
CPB Monthly Vol 49 June 2011
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- Is China Cleaning Up Its Act? Pharma and the recent pollution scandal
- Dogged by rabies: China bites back at a growing epidemic
- Alex Fowkes on R&D Business Development in China
CPB Monthly Vol 48 May 2011
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- HIV in China: A Retroviral Retrospective
- Drug Distribution: The 12th Five-Year Plan
- Dieter Pfeifer and Rory Budihandojo on API Sourcing in China
CPB Monthly Vol 47 April 2011
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- Ovarian Cancer: Difficulty Conceiving New Therapies
- DRGs: Ominous Prescription for Prescription Drugs
- Dan Zhang, CEO of Foundtain Medical Development on Clinical Development in China
CPB Monthly Vol 46 March 2011
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- Health Policy Notes: Window to the future of China's pharma sector?
- Probing China's Prostate Market
- Herman Schwietert, Invida China GM on China's Contract Sales Organization Market
CPB Monthly Vol 45 January 2011
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- RDPAC on drug sales rep training/certification
- All About Gout: New treatments for an old disease in China
- Roberta Lipson, UFH Chairman on Private Healthcare
CPB Monthly Vol 44 December 2010
Price: 250 USD
Page count: 56
Full Table of Contents (PDF)
Lead articles:
- China Highlights 2010
- Private Healthcare: Take Two
- Paul Boltz, Ropes and Gray